US 2004/0171594 A1 · Use of bis-acid(5-androsten-17-one-3beta-hydroxyl)diester for manufacture pharmaceuticals

Abstract

The invention relates to the application of diacid-(5-androsten-17-one-3β-ol)-diester (formula I) as drug manufacture for arrhythmia, myocardial ischemia, cerebral ischemia, osteoporosis, renal failure and so on. 1

Claims1

Dependent claims

The application of diacid-(5-androsten-17-one-3β-ol)-diester (formula I) was used to manufacture drug to treat arrhythmia, myocardial ischemia, cerebral ischemia, osteoporosis, renal failure and improve immunity in pharmacy fields.

Dependencies are inferred from the claim text.

Facts

Application

10/480,173Filed 9 Dec 2003

Priority

CN 0114864.028 Jun 2001

Published

2 Sep 2004

Term ends

Not estimatedThe source records don’t support an estimate.

Classification9 codes

A61K 31/565
Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids: not substituted in position 17 beta by a…
A61P 9/06
Drugs for disorders of the cardiovascular system: antiarrhythmics
A61P 9/10
Drugs for disorders of the cardiovascular system: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary…
A61P 13/12
Drugs for disorders of the urinary system: of the kidneys

Use of bis-acid(5-androsten-17-one-3beta-hydroxyl)diester for manufacture pharmaceuticals

Life of this patent

Abstract

Claims1

Use of bis-acid(5-androsten-17-one-3beta-hydroxyl)diester for manufacture pharmaceuticals

Life of this patent

Abstract

Claims1